Investors will be keeping an eye on oil prices as protests continue in Iran and U.S. President Donald Trump reportedly is weighing options to intervene.
Anthropic is making it easier for patients and clinicians to use its artificial intelligence chatbot to access medical information, part of a broader push into the lucrative health care sector. The San Francisco-based company on Sunday said that its Claude pr…
The U.S. Food and Drug Administration today announced it is sharing information about the agency’s flexible approach to overseeing chemistry, manufacturing and control (CMC) requirements for cell and gene therapies (CGT).
Another wave of closures has hit Macy’s, with over a dozen locations set to shutter across the nation in the coming months, including one near the Bay Area.
Nvidia (NVDA) CEO Jensen Huang has just cut through the big debate over AI chipmaking, saying that the future of advanced chips runs through Taiwan. By...
America’s AI boom is driving a surge in data center construction—along with rising water demand. Why water is becoming the hidden constraint on AI infrastructure.
Plus, tech billionaires’ ‘Save California’ Signal chat, highlights from the year’s biggest gadget show, the woman running SpaceX and more, in this edition of the Technology newsletter
The super-sized gathering of the biopharma universe known as JPM is important, but it’s not going to make or break the year for biotech, Adam Feuerstein writes.
Private biotechs raised $1B+ pre-JPM conference, led by Parabilis' $305M Series F. Public companies like Arrowhead ($625M) & Alumis ($300M) also secured funding amid sector optimism.
Some lawmakers will meet on Thursday to discuss and edit draft legislation on crypto market structure, with the aim of passing a comprehensive law this year.
President Donald Trump, like any politician whose polling is in the gutter, is desperate for a villain — any villain — to blame for America’s affordability woes. Enter Wall Street.